alexa Biological Markers Changes at the Very Early Stage of Ageing (60-65 Years). Is There a Gender-Related Effect? | OMICS International
ISSN: 2329-8847
Journal of Aging Science
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Biological Markers Changes at the Very Early Stage of Ageing (60-65 Years). Is There a Gender-Related Effect?

Daniela Teixeira1, Mayari E Ishimura1, Ieda M Longo-Maugeri1, Maria L Lebrão2, Yeda AO Duarte2, and Valquiria Bueno1*

1UNIFESP Federal University of São Paulo, Department of Microbiology, Immunology, and Parasitology, Sao Paulo, Brazil

2University of São Paulo USP, Faculty of Public Health, São Paulo, Brazil

*Corresponding Author:
Bueno V
Department of Microbiology
Immunology, and Parasitology
UNIFESP Federal University of São Paulo
Rua Botucatu 862, 04023-900 Sao Paulo, Brazil
Tel: 5511 55496073
Fax: 55 1155496073
Email: [email protected]

Received date: January 07, 2015; Accepted date: April 01, 2015; Published date:April 09, 2015

Citation: Daniela Teixeira, Mayari E Ishimura, Ieda M Longo-Maugeri, Maria L Lebrão, Yeda AO Duarte and Valquiria Bueno (2015) Biological Markers Changes at the Very Early Stage of Ageing (60-65 Years). Is There a Gender-Related Effect?. Aging Sci 3:132. doi: 10.4172/2329-8847.1000132

Copyright: © 2015 Teixeira D, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Aging Science


Aging has been associated with progressive molecular and structural changes causing loss of function in several organs. There is a general hypothesis that very old individuals suffer profound modifications where different domains (immune, metabolic and cognitive) loose the tight functional interconnection present in younger bodies. However, it is not clear how this interconnection is affected at the very early stage of ageing and whether gender plays a role. Therefore, our aim was to evaluate some biological markers in non-institutionalized “healthy individuals” at the very early stage of aging (60 to 65 years old, female and male). Blood was collected and serum creatinine, albumin and glucose were measured. In addition, we evaluated these individuals for lymphocytes phenotype (T CD4+, T CD8+, CD19+) by flow cytometry in peripheral mononuclear blood cells. It was observed that at the early stage of ageing male present higher creatinine and albumin serum levels compared to female. In addition, male had higher percentages of effector memory CD4+ and CD8+ T cells and lower percentages of naive CD8+ T cells. No differences were observed for B cells. These findings suggest that metabolic functions and immune system are compromised in male individuals at the very early stage of ageing and thus gender differences should be considered for the design of new therapies to the elderly.


Ageing; Sex-differences; Immunosenescence; Lymphocyte phenotyping.


The natural/continuous process of ageing is associated with several changes in the organism. It is difficult to precisely identify the beginning of ageing process and in developing countries individuals are designed as “elderly” after 60 years old whereas in developed countries “elderly” are individuals over 65 years old.

Healthy ageing seems to be associated with the low burden of chronic diseases and mainly with the maintenance of a functional immune system [1,2]. Some authors have proposed that metabolism dysfunctions (i.e. kidney deteriorating function) are associated with changes in the immune system [3-5].

Most of the studies in elderly have been performed in blood cells and all of the evaluated components present changes during the ageing process. The oxidative stress has been shown to play a pivotal role in ageing by causing oxidative damage to erythrocytes as both its rate increases in elderly and the efficiency of antioxidative and repair mechanisms decreases. In agreement Kosenko et al. [6] observed that individuals elderly healthy (76.8 ± 3 years old) or with Alzheimer's disease (75 ± 2.6 years old) presented in red blood cells significant decreased activity of glutathione peroxidase (GPx), superoxide dismutase (SOD), and glutathione S-transferase (GLT) in comparison with young adults (33.3 ± 3.33 years old). Ageing has also been characterized by a process named “immunosenescence” with increased incidence and severity of infections, decline in vaccine efficacy, and autoimmunity in older adults affecting both innate and adaptive immune responses. It has been reported that changes occurs during ageing in T lymphocytes with decrease of naive cells along with the accumulation of highly differentiated T cells [7-9]. B lymphocytes in elderly individuals present reduced antibody specificity, affinity, and isotype switch [10-14]. These changes have been associated with reduced protection against new infectious agents and inefficient response to vaccines.

The decrease of naive along with the accumulation of highly differentiated T cells have been explained by the decrease in thymic output [7] and higher susceptibility of naive T cells to apoptosis after antigen activation [8]. CMV infection and malignancies have also been associated with the increase of effector memory T cells [9,15,16]. In addition, it has been reported that the age-related decrease of naive T cells and increase of T effector memory (TEM) in peripheral blood also occurs in bone marrow. These findings suggest that the increase of homeostatic cytokines (i.e. IL-15) during ageing favors the survival an expansion of memory instead of naive cells [17].

Another important event related to changes in immune system during ageing is the declined function of hematopoietic stem cells which is characterized by impaired lymphopoiesis and enhanced myelopoiesis [18-22]. This event could favor the expansion of myeloid-derived suppressor cells (MDSCs) which have been shown to be increased in ageing individuals. MDSCs have been associated with inflammatory conditions such as infections and cancer and could contribute for the suppressive state observed in ageing individuals [23-25].

As cited above most of the studies, including those from our group, focus in the impact of age on T and B cells (adaptive immunity) but recently neutrophils, monocytes (innate immunity), and erythrocytes have received more attention from immune gerontologists as these cells also suffers functional and phenotypical alterations with age and could thus contribute for the increase of chronic diseases and loss of the immune system efficacy. Moreover, a variety of factors play a role in the ageing process and recently it has been proposed that gender affects how ageing develops since infections, chronic diseases, and death are more frequent in elderly male individuals [26-31, reviewed in 32]. However, few studies have evaluated whether gender is related to changes observed in metabolism and immune system during the ageing process. Therefore, in this study we investigated whether there are changes in some parameters of metabolism and in lymphocytes subtypes at the early stage of ageing (60-65 years) and how these alterations occurs in female and male individuals. If we can know in advance what the crucial targets of ageing are it is possible to intervene with improved protocols in vaccination and other therapies and thus prevent more prominent changes during the process.

Materials and Methods

After obtaining the written informed consent from the ageing healthy individuals (23 women and 19 men, 60-65 years old), 3ml of heparinized peripheral blood was collected as approved by the Ethics Committee of the UNIFESP Protocol number 10904/2012.

Peripheral blood mononuclear cells (PBMCs) were isolated by Ficoll-Hypaque density gradient (Amersham Biosciences, Uppsala, Sweden) centrifugation. Cells were viable frozen in RPMI, fetal bovine calf serum, and dimethylsulphoxide –DMSO- (all products from Sigma, St Louis, MO, USA), and stored (-80ºC) until cell phenotyping by flow cytometry analysis.

Cell phenotyping

Frozen PBMCs were thaw and RPMI was added. Cells were centrifuged and the pellet was diluted, counted, and volume adjusted (1 x 106/ml). Cells were surface stained with monoclonal antibodies CD3 APC, CD4 PerCP Cy5.5, CD8 APC Cy7, CD19 PE Cy7, CD27 FITC, and CD45RA PE (eBioscience, CA, USA) for 30 min at 4ºC, washed in staining buffer (PBS with 1% BSA), and centrifuged. Live cells (based on forward and side scatter) were acquired on FACS Canto II using DIVA software (Becton Dickinson, USA). Further analyses of FACS data were performed using FLOWJO 9.3 software (Tree Star, USA).

Clinical parameters

The measurement of clinical parameters (creatinine, albumin, and glucose) was performed in blood using an automatic analyzer Dimension RXL (Siemens Laboratory Diagnostics, Tarrytown, NY, USA).

Statistical analysis

Mann-Whitney test was used for statistical analysis and values of *p ≤ 0.05 were considered significant. All statistical analyses were performed with the aid of GraphPad PRISM software (Graphpad, La Jolla, USA).


In Figure 1A it is possible to observe that at the very early period of ageing (60-65 years) male presented a higher mean serum creatinine (female=0.82 mg/dl versus male=1.02 mg/dl) than female. Male also presented higher mean serum albumin (female=3.71g/dl versus male=3.99 g/dl) compared to female (Figure 1B) whereas mean serum glucose (female=103.2mg/dl versus male=90.9 mg/dl) was similar when male and female were compared (Figure 1C).


Figure 1: Blood levels of creatinine, albumin, and glucose from individuals of 60-65 years old (female versus male).

Changes in the percentage of T (CD4+, CD8+) and B lymphocytes and in CD4/CD8 ratio have been shown during the ageing process. In this study the evaluation of mean CD4+ (female=47.4% versus male=43.3%), CD8+ (female and male=23.2%), CD19+ (female=11.9% versus male=11.2%) and the ratio CD4+/CD8+ (female=2.28 versus male=2.13) showed no statistical difference when female and male at the early stage of ageing (60-65 years) were compared (Figure 2).


Figure 2: (A) Percentage of CD4+, (B) CD8+, (C) CD19+, (D) CD4/CD8 ratio in the peripheral blood from individuals of 60-65 years old (female versus male).

Decrease of naive cells and increase of a memory phenotype is reported in elderly individuals and it has been associated with impaired immune response to new pathogens and vaccination. Therefore, our next step was to investigate whether lymphocytes at different stages of maturation (naive, memory, and effector) show percentage changes in female and male individuals at the early stage of ageing (60-65 years). We performed the phenotype of blood circulating cells by flow cytometry using as markers CD45RA+ and CD27+. The presence of these two markers in T lymphocytes is related with naive function whereas the decrease or loss (CD45RAnegCD27+, CD45RA+CD27neg, and CD45RAnegCD27neg) is related to memory and effector functions [33].

Figure 3C shows that at the early stage of ageing (60-65 years) there was a trend towards higher mean percentage of CD4+ T lymphocyte effector memory (TEM) phenotype in male individuals (female=13.6% versus male=18.1%, p=0.077) whereas other phenotypes (naive, TCM, and TEMRA) presented similar mean percentages when female and male individuals were compared. CD8+ T cells showed a trend towards higher mean expression of naive (Figure 4A) phenotype in female (female=35.5% versus male=29.2%, p=0.065) whereas effector memory (TEM female=10.4% versus male=15.6%, p=0.047) phenotype was significantly higher in male individuals (Figure 4C). CD8+ central memory (TCM) and effector re-expressing RA (TEMRA) T cells were expressed in similar percentages when female and male were compared (Figures 4B and 4D respectively).


Figure 3: (A) Percentage of CD4+ naive, (B) CD4+ central memory, (C) CD4+ effector memory, and (D) CD4+ effector memory reexpressing RA cells in the peripheral blood from individuals of 60-65 years old (female versus male).


Figure 4: (A) Percentage of CD8+ naive, (B) CD8+ central memory, (C) CD8+ effector memory, and (D) CD8+ effector memory reexpressing RA cells in the peripheral blood from individuals of 60-65 years old (female versus male).

Ageing has been associated with alterations in peripheral B cell developmental system leading thus to the imbalance in naive and memory populations and decreased response to new extracellular pathogens. In B cells (CD19+) the expression of CD27 is a marker of primed memory cells (CD19+CD27+) and its engagement promotes the differentiation of memory B cells into plasma cells. Our study showed that both naive and memory phenotype was expressed at similar mean percentages when female and male individuals at the early stage of ageing (60-65 years) were compared (Figure 5A and 5B). We observed a mean percentage of naive B cells over 60% (CD19+CD27-; female=60.8% versus male=62.7%) whereas memory B cells were under 40% (CD19+CD27+; female=37.0% versus male=34.7%).


Figure 5: (A) Percentage of CD19+CD27- naive and (B) CD19+CD27+ memory cells in the peripheral blood from individuals of 60-65 years old (female versus male).


Recent findings point to the importance of the immune system integrity for a healthy ageing. Therefore, it is crucial to understand how changes occur in the immune system during the ageing process and the associated events.

Bucci et al [34] followed centenarians for five years and found that individuals who reached longer survival presented similar serum creatinine compared to those who lived less (1.03 ± 0.37 and 0.99 ± 0.3 mg/dL respectively). Instead, longer survival was related to CD4+ and CD8+ higher percentage of naive cells, higher ratio activated/memory and effector/memory phenotype suggesting that in very old individuals the immune system is more susceptible to changes than renal function and could have a significant impact on survival. In our study, at the early stage of ageing (60-65 years), male individuals presented significantly higher mean serum creatinine (female=0.82 mg/dl versus male=1.02 mg/dL) than female along with lower percentage of naive CD8+ T cells (female=35.5% versus male=29.2%) and higher percentage of T effector memory CD4+ (female=13.6% versus male=18.1%) and CD8+ (female=10.4% versus male=15.6%) suggesting more changes in the immune system of the male gender.

Weinberger et al [35] found that CD4+ T lymphocytes are less susceptible to age-related phenotypic and functional changes than CD8+ T cells. In agreement we found for CD4+ T cells that only the effector memory (TEM) phenotype showed a trend towards higher mean percentage in male than in female individuals (p=0.077). For CD8+ T cells we observed changes in two subtypes leading to a lower percentage of naive and a higher percentage of TEM in male compared to female individuals.

In healthy adult donors Hamann et al [36] observed for CD8+ T cells 55 ± 17% of naive, 25 ± 11% of TCM, 4 ± 3% of TEM, and 13 ± 13% of TEMRA. Comparing with Hamann’s data our results showed for both gender at the early stage of ageing (60-65 years) a lower mean percentage of naive (female=35.5% versus male=29.2%) and a higher mean percentage of TEM (female=10.4% versus male=15.6%) and TEMRA (female=32.4% versus male=33.1%) CD8+ cells. Although our data are in line with other authors’ findings confirming that the ageing process is characterized by accumulation of senescent CD8+ T cells which were in our study more prominent in male individuals, functional evaluation and other senescence markers are crucial to confirm our hypothesis. Henson et al. [37] found that CD8+ TEMRA (median 22%) from healthy young individuals presented low proliferative activity and senescence features (KLRG1, CD57, γH2AX) but were still capable of cytotoxic activity and secretion of TNF-α and IFN-γ after activation. Moreover, in senescent CD8+ T cells anaerobic glycolysis was preferentially used to generate energy, these cells produced more reactive oxygen species (ROS), had more mitochondrial dysfunction and lowest telomerase activity after stimulus. The group [38] also evaluated elderly individuals (65-82 years old) and found that senescence features (KLRG1, CD57, γH2AX) were significantly higher expressed in ageing individuals compared to young adults. In addition, in elderly individuals the proliferative capability of naive and EMRA CD8+ T cells was lower and telomerase activity decreased in all subtypes of CD8+ T cells. Intriguingly, naive and EMRA CD8+ T cells from elderly were capable of significant higher production of TNF-α and IFN-γ and naive cells from elderly expressed higher percentage of perforin and granzyme in opposite to EMRA CD8+ T cells. They also found that targeting (inhibition) of both the p38 MAPK (senescence) and PD-1 (exhaustion) pathways increases their proliferative responses to polyclonal and antigen-specific stimuli while maintained the effector capacity which could be an important strategy during vaccination.

Ageing also affects B cells (humoral response) and in addition to the decreased percentage of the naive phenotype it has been reported that elderly subjects present reduced antibody specificity, affinity and isotype switch which contribute for the impairment in the protection against infections and poor response to vaccines [39]. Bancos & Phipps [40] observed a mean percentage of 40% for naive and 60% for memory B cells in the peripheral blood of elderly subjects. In opposite, we observed a mean percentage of naive B cells over 60% (female=60.8% versus male=62.7%) whereas memory B cells were under 40% (female=37.0% versus male=34.7%). This difference could be due to our studied population that was at the early stage of ageing (60-65, n=23 female and 19 male) whereas [40] evaluated individuals were older (60 to 72 years old; n=6 female and 3 male). We did not find any differences in the percentages of naive and memory B cells when female and male were compared. Other changes instead of number could occur in B cells at the early stage of ageing such as inadequate function, insufficient help from T cells with consequences for antibody production, specificity, affinity and isotype [41].

Several studies have shown that male suffer higher morbidity and mortality compared to female due to infections [26-30]. Also, a more efficient immune response is obtained in female after vaccinations [31]. Considering influenza vaccine one study showed that female receiving half dose developed similar antibodies in relation to male receiving full dose [42]. A Japanese study showed age-related changes in lymphocyte subsets suggesting a faster progression of immunosenescence in men with a more pronounced decline of T cells including naive CD4+ and CD8+CD28+, B cells, T-cell proliferative capacity, and IL-6 secretion, and a weaker increase in CD4+ memory T cells and NK cells [43]. In agreement we found that male individuals at the very early stage (60-65 years) are more negatively affected by changes in T cells.

In conclusion, in our studied population the very early stage of ageing (60-65 years) was characterized by more prominent changes in male individuals such as higher mean creatinine levels in serum and increase of memory in detriment of naive T cells in peripheral blood. Functional studies in lymphocytes and oxidative stress in erythrocytes are required to confirm our hypothesis and in case of positive association gender differences should be considered for vaccination strategies and development of new therapies.


This work was supported by FAPESP São Paulo Research Foundation (2012/51747-6), and National Council of Technological and Scientific Development (CNPq).


  1. Fontana L (2009) Modulating human aging and age-associated diseases. Biochim Biophys Acta 1790: 1133-1138.
  2. Vallejo AN (2007) Immune remodeling: lessons from repertoire alterations during chronological aging and in immune-mediated disease. Trends Mol Med 13: 94-102.
  3. Villacres MC, Longmate J, Auge C, Diamond DJ (2004) Predominant type 1 CMV-specific memory T-helper response in humans: evidence for gender differences in cytokine secretion. Hum Immunol 65: 476-485.
  4. Wagner HJ, Hornef M, Teichert HM, Kirchner H (1994) Sex difference in the serostatus of adults to the Epstein-Barr virus. Immunobiology 190: 424-429.
  5. Marriott I, Huet-Hudson YM (2006) Sexual dimorphism in innate immune responses to infectious organisms. Immunol Res 34: 177-192.
  6. Offner PJ, Moore EE, Biffl WL (1999) Male gender is a risk factor for major infections after surgery. Arch Surg 134: 935-938.
  7. Klein SL1 (2004) Hormonal and immunological mechanisms mediating sex differences in parasite infection. Parasite Immunol 26: 247-264.
  8. Klein SL, Jedlicka A, Pekosz A (2010) The Xs and Y of immune responses to viral vaccines. Lancet Infect Dis 10: 338-349.
  9. Fagnoni FF, Vescovini R, Passeri G, Bologna G, Pedrazzoni M, et al. (2000) Shortage of circulating naive CD8(+) T cells provides new insights on immunodeficiency in aging. Blood 95: 2860-2868.
  10. Gupta S, Gollapudi S (2008) CD95-mediated apoptosis in naïve, central and effector memory subsets of CD4+ and CD8+ T cells in aged humans. Exp Gerontol 43: 266-274.
  11. Derhovanessian E, Maier AB, Hähnel K, Beck R, de Craen AJ, et al. (2011) Infection with cytomegalovirus but not herpes simplex virus induces the accumulation of late-differentiated CD4+ and CD8+ T-cells in humans. J Gen Virol 92: 2746-2756.
  12. Frasca D, Landin AM, Lechner SC, Ryan JG, Schwartz R, et al. (2008) Aging down-regulates the transcription factor E2A, activation-induced cytidine deaminase, and Ig class switch in human B cells. J Immunol 180: 5283-5290.
  13. Frasca D, Diaz A, Romero M, Landin AM, Phillips M, et al. (2010) Intrinsic defects in B cell response to seasonal influenza vaccination in elderly humans. Vaccine 28: 8077-8084.
  14. Frasca D, Diaz A, Romero M, Landin AM, Blomberg BB (2011) Age effects on B cells and humoral immunity in humans. Ageing Res Rev 10: 330-335.
  15. Schenkein JG, Park S, Nahm MH (2008) Pneumococcal vaccination in older adults induces antibodies with low opsonic capacity and reduced antibody potency. Vaccine 26: 5521-5526.
  16. Cancro MP, Hao Y, Scholz JL, Riley RL, Frasca D, et al. (2009) B cells and aging: molecules and mechanisms. Trends Immunol 30: 313-318.
  17. Busch A, Zeh D, Janzen V, Mügge LO, Wolf D, et al. (2014) Treatment with lenalidomide induces immunoactivating and counter-regulatory immunosuppressive changes in myeloma patients. Clin Exp Immunol 177: 439-453.
  18. Jitschin R, Braun M1, Büttner M2, Dettmer-Wilde K3, Bricks J1, et al. (2014) CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs. Blood 124: 750-760.
  19. Warren LA, Rossi DJ (2009) Stem cells and aging in the hematopoietic system. Mech Ageing Dev 130: 46-53.
  20. Morita Y, Ema H, Nakauchi H (2010) Heterogeneity and hierarchy within the most primitive hematopoietic stem cell compartment. J Exp Med 207: 1173-1182.
  21. Wang J, Geiger H, Rudolph KL (2011) Immunoaging induced by hematopoietic stem cell aging. Curr Opin Immunol 23: 532-536.
  22. Pang WW, Price EA, Sahoo D, Beerman I, Maloney WJ, et al. (2012) A modern understanding of the traditional and nontraditional biological functions of the angiotensin-converting enzyme. Pharmacol Rev 65: 1-46.
  23. Pang WW, Price EA, Sahoo D, Beerman I, Maloney WJ, et al. (2011) Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age. Proc Natl Acad Sci U S A 108: 20012-20017.
  24. Beerman I, Bhattacharya D, Zandi S, Sigvardsson M, Weissman IL, et al. (2010) Functionally distinct hematopoietic stem cells modulate hematopoietic lineage potential during aging by a mechanism of clonal expansion. Proc Natl Acad Sci U S A 107: 5465-5470.
  25. Verschoor CP, Johnstone J, Millar J, Dorrington MG, Habibagahi M, et al. (2013) Blood CD33(+)HLA-DR(-) myeloid-derived suppressor cells are increased with age and a history of cancer. J Leukoc Biol 93: 633-637.
  26. Bueno V, Sant'Anna OA, Lord JM (2014) Ageing and myeloid-derived suppressor cells: possible involvement in immunosenescence and age-related disease. Age (Dordr) 36: 9729.
  27. Herndler-Brandstetter D, Landgraf K, Tzankov A, Jenewein B, Brunauer R, et al. (2012) The impact of aging on memory T cell phenotype and function in the human bone marrow. J Leukoc Biol 91: 197-205.
  28. Henson SM, Riddell NE, Akbar AN (2012) Properties of end-stage human T cells defined by CD45RA re-expression. Curr Opin Immunol 24: 476-481.
  29. Bucci L, Ostan R, Giampieri E, Cevenini E, Pini E, et al. (2014) Immune parameters identify Italian centenarians with a longer five-year survival independent of their health and functional status. Exp Gerontol 54: 14-20.
  30. Weinberger B, Lazuardi L, Weiskirchner I, Keller M, Neuner C, et al. (2007) Healthy aging and latent infection with CMV lead to distinct changes in CD8+ and CD4+ T-cell subsets in the elderly. Hum Immunol 68: 86-90.
  31. Hamann D, Baars PA, Rep MH, Hooibrink B, Kerkhof-Garde SR, et al. (1997) Phenotypic and functional separation of memory and effector human CD8+ T cells. J Exp Med 186: 1407-1418.
  32. Frasca D, Blomberg BB (2011) Aging affects human B cell responses. J Clin Immunol 31: 430-435.
  33. Bancos S1, Phipps RP (2010) Memory B cells from older people express normal levels of cyclooxygenase-2 and produce higher levels of IL-6 and IL-10 upon in vitro activation. Cell Immunol 266: 90-97.
  34. Weksler ME (2000) Changes in the B-cell repertoire with age. Vaccine 18: 1624-1628.
  35. Engler RJ, Nelson MR, Klote MM, VanRaden MJ, Huang CY, et al. (2008) Half- vs full-dose trivalent inactivated influenza vaccine (2004-2005): age, dose, and sex effects on immune responses. Arch Intern Med 168: 2405-2414.
Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Recommended Conferences

Article Usage

  • Total views: 12296
  • [From(publication date):
    specialissue-2015 - Jul 21, 2018]
  • Breakdown by view type
  • HTML page views : 8442
  • PDF downloads : 3854

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals


[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7